10.14260/jemds/2020/469 413
The fatty acid acylation of cagrilintide enables albumin binding in circulation, reducing renal clearance and extending the elimination half-life to support once-weekly dosing
New developments in AMPK and mTORC1 cross-talk
In animal models and in the clinical setting, distinct pharmaceuticals have been described to modulate the function of transporters or enzymes involved in the metabolic dynamics of amino acids (Table 11)
According to Italian researchers from the Department of Experimental Medicine, Section of General Pathology (Genoa) , glutathione deficiency causes cells to be more vulnerable to oxidative stress, which contributes to cancer development
While there are several published clinical trials on TB-500, the peptide is not approved by the FDA for human use but is generally available for research purposes